Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors
Recruiting now
Conditions studied: Bone and Soft Tissue Tumors, Bone Metastases From Solid Tumors, Lung Metastases
In brief
The goal of this observational study is to learn how tumor tissue and blood samples from patients with sarcomas or metastases can be used to create laboratory models that help researchers study cancer behavior and test new treatments. Participants diagnosed with sarcoma or with bone or lung metastases from solid tumors will donate leftover tumor tissue and blood collected during their regular medical care. These samples will be used in the lab to build 3D models of the tumor, test drugs, and identify genetic and molecular markers. No treatments or procedures will be given as part of the study.
Key facts
- Study ID
- NCT07112989
- Run by
- Istituto Ortopedico Rizzoli
- People needed
- 125
- Starts
- 2024-09-23
- Expected to finish
- 2031-09-23
- Last updated by the study team
- 2025-08-08
Who can join
Age: any, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients (male or female) diagnosed with sarcoma or with bone or lung metastases from solid tumors
- Age between 0 and 85 years
- Availability of sufficient and adequate biological material (tumor tissue and/or blood)
- Signed informed consent for biobanking (BIOTUM)
- Signed informed consent for use of tissue and blood samples in this study
You may not qualify if…
- Diagnosis other than sarcoma or metastases from solid tumors
- Missing signed informed consent(s)
Where it is running
- Istituto Ortopedico Rizzoli — Bologna, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.